A survey of the use of herbs among patients attending secondary-level health care facilities in Southwestern Nigeria

Journal of Herbal Pharmacotherapy

Volumn 7, Issue 3-4, 2007, Pages 213-227

  Fakeye, Titilayo Oyelola ^a   Tijani, Abu ^a   Adebisi, O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Herb use; Interaction; Patients; Secondary health care facility

Indexed keywords

ALCOHOL; ANTIHISTAMINIC AGENT; AZADIRACHTA INDICA EXTRACT; CARICA PAPAYA EXTRACT; CASSIA EXTRACT; CYBOPOGON CITRATE EXTRACT; GARLIC EXTRACT; GENTAMICIN; GINKGO BILOBA EXTRACT; HALOFANTRINE; HERBACEOUS AGENT; IBUPROFEN; MANGIFERA INDICA EXTRACT; MORINDA LUCIDA EXTRACT; ONION EXTRACT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; QUININE; UNCLASSIFIED DRUG; VERNONIA AMYGDALINA EXTRACT; WATER; PLANT MEDICINAL PRODUCT;

ADOLESCENT; ADULT; ALCOHOLIC BEVERAGE; ARTICLE; ASTHMA; ATTITUDE TO HEALTH; CEREBROVASCULAR ACCIDENT; CHILD; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; EDUCATIONAL STATUS; EUPHORIA; EXPERIENCE; FEMALE; GASTROINTESTINAL INFECTION; HEALTH SURVEY; HEMORRHOID; HERB DRUG INTERACTION; HERBAL MEDICINE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INFORMATION DISSEMINATION; LEISURE; MAJOR CLINICAL STUDY; MALARIA; MALE; NAUSEA; NIGERIA; OUTPATIENT; PAIN; PATIENT ATTITUDE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RURAL AREA; SCHOOL CHILD; SELF MEDICATION; STOMACH PAIN; STROKE; VOMITING; CROSS-SECTIONAL STUDY; HEALTH BEHAVIOR; HUMAN RELATION; METHODOLOGY; MIDDLE AGED; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SELF CARE; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERB-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED; NIGERIA; PHYTOTHERAPY; PLANT PREPARATIONS; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; SELF CARE; SELF MEDICATION;

EID: 58149154201     PISSN: 15228940     EISSN: 15229106     Source Type: Journal    
DOI: 10.1080/15228940802152901     Document Type: Article

References (44)

1. May, F. E., Stewart, R. B. and Cliff, L. E. (1977) Drug interactions and multiple drug administration. Clin Pharmacol Ther, 22, p. 322.
2. Ledwidge, M., Travers, B., Ryder, M., Ryan, E. and McDonald, K. (2004) Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug interactions. Eur J Heart Fail, 6:2, pp. 235-243.
3. Karas Jr, S. (1981) The potential for drug interactions. Ann Emerg Med, 10, pp. 627-630.
4. Haase, G., Pietzsch, M., Fahnrich, A., Voss, W. and Riethling, A. K. (2002) Results of a systematic adverse drug reaction (ADR)-screening concerning bradycardia caused by drug interactions in departments of internal medicine in Rostock. Int J Clin Pharmacol Ther, 40:3, pp. 116-119.
5. Kohler, G. I., Bode-Boger, S. M., Busse, R., Hoopmann, M., Welte, T. and Boger, R. H. (2000) Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther, 38:11, pp. 504-513.
6. Yamreudeewong, W., De Bisschop, M., Martin, L. G. and Lower, D. L. (2003) Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf, 26:6, pp. 421-438.
7. Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J. and Kivisto, K. T. (2003) Pharmacokinetic interactions with rifampicin: Clinical relevance. Clin Pharmacokinet, 42:9, pp. 819-850.
8. Puckett Jr, W. H. and Visconti, J. A. (1971) An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. Am J Hosp Pharm, 28:4, pp. 247-253.
9. Stanton, L. A., Peterson, G. M., Rumble, R. H., Cooper, G. M. and Polack, A. R. (1994) Drug-related admissions to an Australian hospital. J Clin Pharmacol Ther, 19, pp. 341-347.
10. Classen, D. C., Pestotnik, S. L., Evans, R. S., Lloyd, J. F. and Burke, J. P. (1997) Adverse drug events in hospitalized patients. J Am Med Assoc, 277, pp. 301-306.
11. Lazarou, J., Pomeranz, B. and Corey, P. N. (1998) Incidence of adverse drug reactions in hospitalized patients: A meta analysis of prospective studies. J Am Med Assoc, 279, pp. 1200-1205.
12. Zhou, S., Chan, E., Pan, S. Q., Huang, M. and Lee, E. J. (2004) Pharmacokinetic interactions of drug with St. John's wort. J Psychopharmacol, 18:2, pp. 262-276.
13. Drew, A. K. and Myers, S. P. (1997) Safety issues in herbal medicine: implications for health professions. Med J Aust, 166, pp. 538-541.
14. Mai, I., Knuger, H. Budde, K. et al. (2000) Hazardous pharmacokinetics interaction of St. Johns' wort (Hypericum perforatum) with immunosuppressant cyclosporine. Int J Clin Pharmacol Ther, 38, pp. 500-502.
15. Guengerich, F. P. (1997) Role of cytochrome P450 enzymes in drug-drug interactions. Drug-drug interactions: Scientific and regulatory perspectives, pp. 7-35. Academic Press, San Diego
16. Michalets, E. L. (1998) Update: Clinically significant cytochrome P450 drug interactions. Pharmacother, 18, pp. 84-112.
17. Shaw, D., Leon, C., Kolev, S. and Murray, V. (1997) Traditional remedies and food supplements: A five year toxicological study (1991-1995). Drug Saf, 17, pp. 342-356.
18. Rosenblatt, M. and Mindel, J. (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med, 336, p. 1108.
19. Matthews Jr, M. K. (1998) Association of Ginkgo biloba with intracerebral hemorrhage. Neurology, 50, p. 1933.
20. Janetzky, K. and Morreale, A. P. (1997) Probable interaction between warfarin and ginseng. Am J Health Syst Pharm, 54, pp. 692-693.
21. Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St. John wort (Hypericum perforatum). Clin Pharmacol Ther, 66, pp. 338-345.
22. Maurer, A., Johne, A. Bauer, S. et al. (1999) Interaction of St John's wort extract with phenprocoumon. Eur J Clin Pharm, 55, p. A22.
23. Ruschitzka, F., Meier, P. J., Turina, M., Luscher, T. F. and Noll, G. (2000) Acute heart transplant rejection due to St. Johns' wort. Lancet, 355, pp. 548-549.
24. Barone, G. W., By, Gurley, Ketel, B. L. and Abul-Ezz, S. R. (2001) Herbal supplements: A potential for drug interactions in transplant recipients. Transplantation, 71, pp. 239-241.
25. Durr, D., Stieger, B. Kullak-Ublick, G. A. et al. (2000) St. John's wort induces intestinal P-glycoprotein/MDR I and intestinal and hepatic CYP3A4. Clin Pharmacol Ther, 68, pp. 598-604.
26. Markowitz, J. S., De Vane, C. L., Boulton, D. W., Carson, S. W., Nahas, Z. and Risch, S. C. (2000) Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci, 66, p. PL133.
27. Roby, C. A., Anderson, G. D., Kantor, E., Dnyer, D. A. and Burstein, A. H. (2000) St John's wort-effect on CYP3A4 activity. Clin Pharmacol Ther, 67, pp. 451-457.
28. Fugh-Berman, A. and Ernst, E. (2001) Herb-drug interaction: Review and assessment of report reliability. Br J Clin Pharmacol, 52, pp. 587-595.
29. Izzo, A. A. and Ernst, E. (2001) Interactions between herbal medicines and prescribed drugs: A systematic review. Drugs, 61, pp. 2163-2175.
30. Shinozuka, K., Umegaki, K. Kubota, Y. et al. (2002) Feeding of Gingko biloba extract (GBE) enhance gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci, 70, pp. 2783-2792.
31. Jiang, X., Williams, K. M. Liauw, W. S. et al. (2004) Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharm, 57:5, pp. 592-599.
32. Nose, M., Tamura, M., Ryu, N., Mizukami, H. and Ogihara, Y. (2003) Sho-saiko-to and saiko-keishi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J Pharm Pharmacol, 55, pp. 1419-1426.
33. Foster, B. C., Foster, M. S. Vandenhoek, S. et al. (2001) An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci, 4:2, pp. 176-184.
34. Ho, P. C., Ghose, K., Saville, D. and Wanwimolruk, S. (2000) Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur J Clin Pharm, 56:9, pp. 693-698.
35. Lane, H. Y., Jann, M. W. Chang, Y. C. et al. (2001) Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability. J Clin Psychol, 62:10, pp. 812-817.
36. Tassaneeyakul, W., Vannaprasaht, S. and Yamazoe, Y. (2001) Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharm, 49920, pp. 139-144.
37. Chen, L., Mohr, S. N. and Yang, C. S. (1996) Decrease of plasma and urinary oxidative metabolites of acetaminophen after consumption of watercress by human volunteers. Clin Pharm Ther, 60:6, pp. 651-660.
38. Fugh-Berman, A. (2000) Herb-drug interactions. Lancet, 355, pp. 134-138.
39. Horn, J. R. and Hansten, P. D. (2004) Drug Interactions: Insights and observations-hyperkalaemia due to drug interactions. Pharm Times, pp. 66-67.
40. Kuo, G. M., Hawley, S. T., Weiss, L. T., Balkrishnan, R. and Volk, R. J. (2004) Factors associated with herbal use among urban multiethnic primary care patients: A cross-sectional survey. BMC Complement Altern Med, 4, p. 18.
41. Richard, Ko (1999) Adverse reactions to watch for in patients using herbal remedies. West J Med, 171:3, pp. 181-186.
42. Kolawole, J. A. and Maduenyi, A. (2004) Effect of zobo (Hibiscus sabdariffa water extract) on the pharmacokinetics of acetaminophen in human volunteers. Eur J Drug Metab Pharmacokinet, 29:1, pp. 25-29.
43. Saxena, A. K. and Panholta, B. R. (2003) Herbal remedies-renal tragedies. Swiss Med Wkly, 133, pp. 188-189.
44. Giveon, S. M., Liberman, N., Klang, S. and Kahan, E. (2003) A survey of primary care physicians' perceptions of their patients' use of complimentary medicine. Complement Ther Med, 11:4, pp. 254-260.